Ubs Asset Management Americas Inc Bridge Bio Pharma, Inc. Transaction History

Ubs Asset Management Americas Inc

$379 Billion
Q1 2025

A detailed history of Ubs Asset Management Americas Inc transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 604,946 shares of BBIO stock, worth $22.7 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

604,946

Previous 609,588 0.76%

Holding current value

$22.7 Million

Previous $16.7 Million 25.02%

% of portfolio

0.01%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 19, 2025	SELL	$28.12 - $37.59 $130,533 - $174,492	-4,642 Reduced 0.76%	604,946 $20.9 Million
Q4 2024 Feb 14, 2025	SELL	$22.35 - $29.5 $1.13 Million - $1.49 Million	-50,677 Reduced 7.68%	609,588 $16.7 Million
Q3 2024 Nov 14, 2024	SELL	$23.91 - $31.3 $1.1 Million - $1.44 Million	-45,862 Reduced 6.49%	660,265 $16.8 Million
Q2 2024 Aug 13, 2024	BUY	$23.0 - $31.04 $1.48 Million - $1.99 Million	64,232 Added 10.01%	706,127 $17.9 Million
Q1 2024 May 15, 2024	SELL	$27.35 - $40.45 $501,134 - $741,165	-18,323 Reduced 2.78%	641,895 $19.8 Million
Q4 2023 Feb 14, 2024	SELL	$24.02 - $43.89 $850,668 - $1.55 Million	-35,415 Reduced 5.09%	660,218 $26.7 Million
Q3 2023 Nov 13, 2023	SELL	$16.89 - $35.01 $149,527 - $309,943	-8,853 Reduced 1.26%	695,633 $18.3 Million
Q1 2023 May 15, 2023	BUY	$7.17 - $18.55 $4.31 Million - $11.1 Million	600,521 Added 577.62%	704,486 $11.7 Million
Q4 2022 Feb 14, 2023	SELL	$6.74 - $11.52 $26,104 - $44,616	-3,873 Reduced 3.59%	103,965 $792,000
Q3 2022 Nov 14, 2022	BUY	$7.94 - $12.36 $183,811 - $286,134	23,150 Added 27.34%	107,838 $1.07 Million
Q2 2022 Aug 12, 2022	BUY	$5.21 - $12.14 $100,183 - $233,440	19,229 Added 29.38%	84,688 $768,000
Q1 2022 May 16, 2022	BUY	$7.34 - $17.16 $3,655 - $8,545	498 Added 0.77%	65,459 $664,000
Q4 2021 Feb 14, 2022	SELL	$11.38 - $53.41 $65,264 - $306,306	-5,735 Reduced 8.11%	64,961 $1.08 Million
Q3 2021 Nov 15, 2021	BUY	$46.87 - $64.24 $70,914 - $97,195	1,513 Added 2.19%	70,696 $3.31 Million
Q2 2021 Aug 16, 2021	BUY	$46.47 - $63.93 $1.38 Million - $1.9 Million	29,742 Added 75.41%	69,183 $4.22 Million
Q1 2021 May 14, 2021	SELL	$55.47 - $72.35 $6.99 Million - $9.11 Million	-125,961 Reduced 76.15%	39,441 $2.43 Million
Q4 2020 Mar 01, 2021	SELL	$38.38 - $71.11 $345,151 - $639,492	-8,993 Reduced 5.16%	165,402 $11.8 Million
Q3 2020 Nov 13, 2020	SELL	$27.2 - $42.19 $69,523 - $107,837	-2,556 Reduced 1.44%	174,395 $6.54 Million
Q2 2020 Aug 14, 2020	BUY	$22.22 - $35.69 $177,871 - $285,698	8,005 Added 4.74%	176,951 $5.77 Million
Q1 2020 May 15, 2020	BUY	$16.11 - $36.23 $1.49 Million - $3.34 Million	92,212 Added 120.17%	168,946 $4.9 Million
Q4 2019 Feb 14, 2020	SELL	$17.96 - $46.63 $3,897 - $10,118	-217 Reduced 0.28%	76,734 $2.69 Million
Q3 2019 Nov 14, 2019	BUY	$20.13 - $32.38 $39,273 - $63,173	1,951 Added 2.6%	76,951 $1.65 Million
Q2 2019 Aug 15, 2019	BUY	$26.97 - $27.55 $2.02 Million - $2.07 Million	75,000 New	75,000 $0

Others Institutions Holding BBIO

# of Institutions

362

Shares Held

185M

Call Options Held

12.8M

Put Options Held

2.09M

View Full List

About BridgeBio Pharma, Inc.

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $5.56B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

More about BBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.

Account

Ubs Asset Management Americas Inc Bridge Bio Pharma, Inc. Transaction History